Exabis Library
Welcome to the e-CCO Library!
P643: Generalizability of Crohn’s disease randomized controlled trials compared to clinical practice
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P643: Patient perspectives and expectations in inflammatory bowel disease: a systematic review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P643: Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P643: Therapeutic thresholds for infliximab trough levels during maintenance treatment in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P644 Post-operative Crohn’s disease recurrence in Glasgow: How common is it and does deprivation matter?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P644: Effectiveness of vedolizumab on intestinal outcomes and articular manifestations: Real-world data from the Sicilian Network for inflammatory bowel disease (SN-IBD)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P644: Factors and salvage surgery for treatment of pouch failure after restorative proctocolectomy for ulcerative colitis – a single-institution study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P644: Hospitalization and abdominal surgery rates in CD according to drug-dispensing: a temporal trend analysis from the Brazilian public healthcare national system
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P644: Impact of Postoperative Treatment with Immunomodulators and Anti-TNFα agents on long-term Reoperation Rate in ileocaecal Crohn’s Disease.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P644: Leucine-rich alpha 2 glycoprotein- A useful biomarker to discriminate small intestinal mucosal healing in asymptomatic CRP-negative Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P644: Mindfulness-based stress reduction in adult patients with active Crohn's disease: preliminary findings based on the subjective units of distress scale: an IIRN study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P645 Adalimumab drug monitoring is superior to empirical treatment adjustment in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P645: Dynamics of proinflammatory cytokines in patients with Crohn's disease who received combined therapy with mesenchymal stromal cells of bone marrow and azathioprine
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P645: Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD Registry
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P645: Mental health, work presenteeism and exercise in IBD patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P645: Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P645: The introduction of infliximab therapeutic drug level monitoring for is associated with cost savings in a cohort of patients in a large district general hospital
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P645: Use of Leukocytapheresis in inflammatory bowel disease in paediatric patients. A serie of 10 cases.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P646 Utilisation of indocyanine green fluorescence imaging for Crohn’s disease following intestinal resection
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P646: Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM